T.cruzi-IN-1 d-C2-PEG3-NHS ester 2ClH/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26

2ClH/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26

significantly (p≤0

InChi: InChI=1S/C28H28F2N6O3/c29-20-6-1-4-17(23(20)30)18-8-9-22(25-19(24(18)31)5-2-12-32-25)39-28(38)35-14-10-16(11-15-35)36-21-7-3-13-33-26(21)34-27(36)37/h1-7

Study of human isoursodeoxycholic acid metabolism

with an EC50 of approximately 4 μM

T.cruzi-IN-1 d-C2-PEG3-NHS ester 2ClH/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26T. cruzi IN 1 is a potent Trypanosoma cruzi inhibitor with an IC50 of 8 nM. T. cruzi IN 1, a 4 trifluoromethyl substituted analog, has the potential for both the acute and chronic stages of Chagas disease. Product information CAS Number: 1350920 22 7 Molecular Weight: 390. 44 Formula: C22H25F3N2O Chemical Name: N benzyl N methyl 1 {[4 (trifluoromethyl)phenyl]methyl}piperidine 3 carboxamide Smiles: CN(CC1C=CC=CC=1)C(=O)C1CN(CC2C=CC(=CC=2)C(F)(F)F)CCC1